|

SHR-A1904 for Injection Clinical Trials

2 actively recruiting trials

No change since May 2026

Pipeline

Phase 2: 2

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.2

Indications

  • Cancer2
  • Biliary Tract Cancer1
  • Gastric Cancer1
  • Gastroesophageal-junction Cancer1

Other2 trials

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer
Phase 2
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.